ARISTOTLE
A phase III trial comparing standard versus novel CRT as pre-operative treatment for MRI defined locally advanced rectal cancer
ARISTOTLE is a multicentre, phase III, randomised trial comparing standard neoadjuvant chemoradiotherapy (CRT) of oral capecitabine and radiotherapy versus standard CRT with the addition of irinotecan [...]
Area:
Lower gastro-intestinal cancer
Phase:
Phase III
Status:
In follow-up (non-recruiting)